The Trump administration’s trilateral trade agreement with Mexico and Canada will lead to higher drug prices that will harm American consumers, labor and health groups said in a Nov. 5 letter to President
Twenty-nine companies and organizations are urging the administration to revise medical provisions in the USMCA agreement, formerly known as the North American Free Trade Agreement or NAFTA. Signatories to the letter include the AFL-CIO, the Association for Accessible Medicines, AARP, and
The letter was sent to U.S. Trade Ambassador
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.